In a pivotal legal decision on March 31, 2025, a US bankruptcy judge decisively denied Johnson & Johnson’s ambitious $10 billion settlement plan aimed at resolving numerous lawsuits. These lawsuits claim that Johnson & Johnson's talc-based products, notably their iconic Baby Powder, are linked to causing ovarian cancer. This ruling represents a significant blow to the healthcare conglomerate's strategy to manage these allegations through bankruptcy protection.